Clinical trial

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

NCT00700284

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention placebo vaginal ring Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TMC120 (dapivirine) vaginal ring Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE1

Conditions

HIV Infectionsunresolved

Interventions

placebo vaginal ringDRUG

TMC120 (dapivirine) vaginal ringDRUG

Sponsors & collaborators

International Partnership for Microbicides, Inc.lead sponsor

Tibotec Pharmaceutical Limitedcollaborator

Mapped research locations

GhentBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00700284 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.